Systemic and local effect of oxidative stress on recurrent aphthous stomatitis: systematic review.
Cristina EstornutGiulia RinaldiMaría Carmen CarcellerSergio EstornutMartín Pérez-LealPublished in: Journal of molecular medicine (Berlin, Germany) (2024)
Recurrent aphthous stomatitis (RAS) is a chronic and recurrent inflammatory disease of the mouth. It is characterised by the appearance of painful ulcers in the oral mucosa. RAS is believed to be a multifactorial disease with genetic predisposition, environmental factors and alterations in the immune system. Oxidative stress, caused by an imbalance between free radicals and the antioxidant system, also appears to be involved in the pathogenesis of RAS. Several risk factors, such as smoking, iron and vitamin deficiency and anxiety, may contribute to the development of the disease. Understanding the underlying mechanisms may help in the prevention and treatment of RAS. We searched PubMed, Scopus and Web of Science databases for articles on oxidative stress in patients with RAS from 2000 to 2023. Studies analysing oxidant and antioxidant levels in the blood and saliva of RAS patients and healthy controls were selected. Of 170 potentially eligible articles, 24 met the inclusion criteria: 11 studies on blood samples, 6 on salivary samples and 7 on both blood and salivary samples. Multiple oxidative and antioxidant markers were assessed in blood and saliva samples. Overall, statistically significant differences were found between RAS patients and healthy controls for most markers. In addition, increased oxidative DNA damage was observed in patients with RAS. Patients with RAS show elevated levels of oxidative stress compared to healthy controls, with a significant increase in oxidative markers and a significant decrease in antioxidant defences in saliva and blood samples.
Keyphrases
- oxidative stress
- wild type
- dna damage
- systematic review
- end stage renal disease
- ischemia reperfusion injury
- diabetic rats
- newly diagnosed
- risk factors
- induced apoptosis
- chronic kidney disease
- ejection fraction
- anti inflammatory
- public health
- randomized controlled trial
- patient reported outcomes
- depressive symptoms
- genome wide
- big data
- tyrosine kinase